Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
Primary Purpose
Percutaneous Coronary Artery Intervention, Coronary Artery Bypass Graft, Acute Coronary Syndrome
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
cipher prescription 1
cipher prescription 2
Sponsored by
About this trial
This is an interventional treatment trial for Percutaneous Coronary Artery Intervention focused on measuring percutaneous coronary artery intervention, coronary artery bypass graft, acute coronary syndrome
Eligibility Criteria
Inclusion Criteria:
- age40~75
- angina or CAD patient
- deficiency of heart-QI and blockage of phlegm and blood stasis in chinese medicine
- 1 week after operation,or 1week after drainage tube extraction for CABG
- sign a informed consent
Exclusion Criteria:
- severe cardia failure
- severe renal inadequacy
- complicating with malignant tumor,reactive alimentary tract hemorrhage and haematological systemic disorder etc.
- psychotic
- pregnant,lactation
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
managed group
control group
Arm Description
Outcomes
Primary Outcome Measures
dead
Secondary Outcome Measures
cardiovascular event
Full Information
NCT ID
NCT00965471
First Posted
August 24, 2009
Last Updated
August 24, 2009
Sponsor
Guangzhou University of Chinese Medicine
Collaborators
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Guangdong Provincial People's Hospital, China-Japan Friendship Hospital, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Teaching Hospital of Nanjin University of Traditional Chinese Medicine, Second People's Hospital, Fujian Province, Liaoning University of Traditional Chinese Medicine, Guangzhou Overseas Chinese Hospital, Beijing Tongren Hospital, Shanghai 10th People's Hospital, PLA.The Military General Hospital of Beijing, The Sixth Affliated Hospital of Jinan University, Beijing Anzhen Hospital, Gansu Provincial Hospital, Shaanxi Provincial People's Hospital, First Affiliated Hospital, Sun Yat-Sen University, The Fifth Affliated Hospital of Guangxi Medical University
1. Study Identification
Unique Protocol Identification Number
NCT00965471
Brief Title
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
Official Title
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
Study Type
Interventional
2. Study Status
Record Verification Date
August 2009
Overall Recruitment Status
Completed
Study Start Date
October 2006 (undefined)
Primary Completion Date
October 2008 (Actual)
Study Completion Date
June 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Guangzhou University of Chinese Medicine
Collaborators
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Guangdong Provincial People's Hospital, China-Japan Friendship Hospital, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Teaching Hospital of Nanjin University of Traditional Chinese Medicine, Second People's Hospital, Fujian Province, Liaoning University of Traditional Chinese Medicine, Guangzhou Overseas Chinese Hospital, Beijing Tongren Hospital, Shanghai 10th People's Hospital, PLA.The Military General Hospital of Beijing, The Sixth Affliated Hospital of Jinan University, Beijing Anzhen Hospital, Gansu Provincial Hospital, Shaanxi Provincial People's Hospital, First Affiliated Hospital, Sun Yat-Sen University, The Fifth Affliated Hospital of Guangxi Medical University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to built the standard of Chinese Traditional Medicine test for Post percutaneous coronary artery intervention and coronary artery bypass graft,also for acute coronary syndrome,according to the multi-site、random large sample test.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Percutaneous Coronary Artery Intervention, Coronary Artery Bypass Graft, Acute Coronary Syndrome
Keywords
percutaneous coronary artery intervention, coronary artery bypass graft, acute coronary syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
940 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
managed group
Arm Type
Experimental
Arm Title
control group
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
cipher prescription 1
Intervention Description
Drug granules include ginseng,RADIX NOTOGINSENG,prepared RHIZOMA PINELLIAE with alumen radix glyrrhigae calcaren once daily for 180 days
Intervention Type
Drug
Intervention Name(s)
cipher prescription 2
Intervention Description
Placebo include amidon、bitter principles and diluents bases once daily for 180 days
Primary Outcome Measure Information:
Title
dead
Time Frame
180±3days
Secondary Outcome Measure Information:
Title
cardiovascular event
Time Frame
180±3days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age40~75
angina or CAD patient
deficiency of heart-QI and blockage of phlegm and blood stasis in chinese medicine
1 week after operation,or 1week after drainage tube extraction for CABG
sign a informed consent
Exclusion Criteria:
severe cardia failure
severe renal inadequacy
complicating with malignant tumor,reactive alimentary tract hemorrhage and haematological systemic disorder etc.
psychotic
pregnant,lactation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruan Xinmin
Organizational Affiliation
Guangzhou University of Chinese Medecine
Official's Role
Study Chair
12. IPD Sharing Statement
Citations:
PubMed Identifier
25592946
Citation
Lin Y, Wang YF, Lin DQ, Chen JW, Li JZ, Lan TH, Ou AH, Ruan XM. Efficacy and safety of Huxin formula in patients after CABG: a multicenter, double-blind, randomized clinical trial. Forsch Komplementmed. 2014;21(6):351-9. doi: 10.1159/000370010. Epub 2014 Dec 11.
Results Reference
derived
Learn more about this trial
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
We'll reach out to this number within 24 hrs